Simcere Pharmaceutical Group Reports Unaudited First Quarter 20...(plicable law. Conference Call ...)

Conference Call

Simcere Pharmaceutical Group will host a conference call to discuss the Company's results for the first quarter 2009 on Tuesday, May 19, at 8 a.m. Eastern Time (Tuesday, May 19, at 8 p.m. Beijing/Hong Kong time). The management team will be on the call to discuss the results for first quarter 2009 and to answer questions.

    To access the conference call, please dial:

     United States toll-free dial-in number: +1 800 659 2056
     International dial-in number:           +1 617 614 2714
     North China toll-free dial-in number:   +86 10 800 152 1490
     South China toll-free dial-in number:   +86 10 800 130 0399
     Hong Kong dial-in number:               +852 3002 1672

Please ask to be connected to Simcere's Q1 2009 earnings call and provide the following passcode: 25770430. Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the Company's web site at http://www.simcere.com .

Following the earnings conference call, an archive of the call will be available by dialing:

United States toll-free dial-in number: +1 888 286 8010

     United States dial-in number:           +1 617 801 6888

The passcode for replay participants is: 21293840. The telephone replay also will be archived on the "Investor Relations" section of the Company's web site for seven days following the earnings announcement.

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group (NYSE: SCR; Simcere) is a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China. In recent years, Simcere has been focusing its stra
'/>"/>